Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Products
  • 研究・開発
  • 研究ソリューション
    • ゲノム解析
    • タンパク質解析
    • 細胞分析
    • 研究ソリューション
  • 疾患研究
    • Biomarker Discovery
    • 細胞・遺伝子治療
    • GMP Workflows
    • Immunoassays Solutions
    • pHSense Reagents
    • バイオロジクス
    • 低分子創薬
    • 疾患研究
    • ターゲットクラス
    • 医薬品開発
    • プレシジョン・メディシン・リサーチ
    • 機能ゲノミクススクリーニングソリューション
    • アッセイ開発ワークフロー
    • Microphysiological Systems
    • Biobanking Workflows
    • Agrigenomics Workflows
  • Infectious Disease Research
    • Cancer Research Solutions
    • Cardiovascular Disease Research
    • Infectious Disease Research
    • Inflammation Research
    • Metabolic Disease
    • Neuroscience Research

Infectious Disease Research

Stay one step ahead of infectious diseases

Infectious diseases continue to take a toll on human health, affecting all aspects of our lives. Fast development of preventative vaccines and therapeutic treatments has become imperative as the increased globalization of our modern world enables the rapid spread of infectious diseases.

Persistent use of antibiotics has provoked the emergence of multidrug resistant bacteria, creating challenges that may be addressed by the research and development of novel therapeutics or combination therapies.

We offer a diverse product portfolio that helps scientists make critical discoveries through genomic analysis, in vitro, cell-based, and in vivo studies, that may enable drug discovery research.


For research use only. Not for use in diagnostic procedures.

Request more information
infectious-disease-research-872x872.jpg
DIG_InfectiousDisease_Icons_Pathogen Genomics

Pathogen genomics

Genetic information from viruses, bacteria and other infectious organisms plays a crucial role in detetection, investigating outbreaks, describing transmission patterns, monitoring antimicrobial resistance and last but not least, developing interventions such as vaccines.Next-generation-sequencing research has made it possible to investigate pathogens as well as microbiome genomes at much greater detail and throughput.

Learn more

Genetic information from viruses, bacteria and other infectious organisms plays a crucial role in detetection, investigating outbreaks, describing transmission patterns, monitoring antimicrobial resistance and last but not least, developing interventions such as vaccines.Next-generation-sequencing research has made it possible to investigate pathogens as well as microbiome genomes at much greater detail and throughput.

Learn more

DIG_InfectiousDisease_Icons_Host Pathogen Interactions

Host pathogen interactions

Understanding host-pathogen interactions on a molecular, cellular or organism level is the basis for drug discovery. To achieve physiological relevant results, today’s infectious disease research moves towards more complex disease models such as co-cultures or organoids that better resemble in vivo biology. Whether you want to analyze cellular models or in vivo models, or study protein:protein interactions and identify PPI inhibitors, we provide the reagents, instruments and software you need to enable these research applications.

Understanding host-pathogen interactions on a molecular, cellular or organism level is the basis for drug discovery. To achieve physiological relevant results, today’s infectious disease research moves towards more complex disease models such as co-cultures or organoids that better resemble in vivo biology. Whether you want to analyze cellular models or in vivo models, or study protein:protein interactions and identify PPI inhibitors, we provide the reagents, instruments and software you need to enable these research applications.

DIG_InfectiousDisease_Icons_Immune Response

Immune response

When a pathogen infects the human body, a battle ensues between the host’s innate & adaptive immune systems and the pathogen’s virulence mechanisms and factors. Pathways such as MAP kinase, JAK/STAT, and NFκB play a central role in the antiviral immune response along with ligands such as IL-6, TNFα, and the INFs (-γ, -α, -β, and -λ). We offer a wide range of reagents, detection and imaging instruments enabling to study the antiviral immune response both in vitro and in vivo.

When a pathogen infects the human body, a battle ensues between the host’s innate & adaptive immune systems and the pathogen’s virulence mechanisms and factors. Pathways such as MAP kinase, JAK/STAT, and NFκB play a central role in the antiviral immune response along with ligands such as IL-6, TNFα, and the INFs (-γ, -α, -β, and -λ). We offer a wide range of reagents, detection and imaging instruments enabling to study the antiviral immune response both in vitro and in vivo.

DIG_InfectiousDisease_Icons_Drug Discovery

Drug discovery

Antimicrobial research and drug discovery requires sensitive and reliable technologies to detect microbial growth and measure antimicrobial effects. We provide solutions to measure bacterial growth or viral titers, perform target-based, high-throughput drug discovery or phenotypic research and characterize bacterial phenotypes for antimicrobial resistance research using high-content analysis.

Antimicrobial research and drug discovery requires sensitive and reliable technologies to detect microbial growth and measure antimicrobial effects. We provide solutions to measure bacterial growth or viral titers, perform target-based, high-throughput drug discovery or phenotypic research and characterize bacterial phenotypes for antimicrobial resistance research using high-content analysis.

DIG_InfectiousDisease_Icons_Viral Diseases and Vaccines

Viral diseases and vaccines

Continued discovery of new antiviral medications and vaccines is important for global human health, particularly as new viruses, like we saw with COVID-19 or novel Influenza viruses, can emerge quickly. We offer solutions for measuring virus neutralization, antiviral compound effects, antiviral immune response or for studying cytokine storm, which is associated with COVID-19.

Learn more

Continued discovery of new antiviral medications and vaccines is important for global human health, particularly as new viruses, like we saw with COVID-19 or novel Influenza viruses, can emerge quickly. We offer solutions for measuring virus neutralization, antiviral compound effects, antiviral immune response or for studying cytokine storm, which is associated with COVID-19.

Learn more

Explore our solutions

cellular imaging and analysis

Cellular Imaging & Analysis

Answer complex cell biology questions with powerful cellular imaging and analysis solutions, including systems, reagents, microplates, software and automation.

Learn more
cell-counting-image-cytometry-1077x606.jpg

Cell Counting and Image Cytometry

Revvity offers a leading portfolio of automated cell counters, image cytometry systems, and cell counting reagents and consumables.

Learn more
in-vivo-imaging344x194.jpg

In Vivo Imaging

Track, monitor, and visualize biological processes and disease progression with our industry-leading in vivo imaging systems and reagents.

Learn more
microplates-512

マイクロプレート

適切なマイクロプレートを選択することは、アッセイにおいて非常に重要ですが、見落とされがちです。正しいマイクロプレートは貴重なデータを提供するのに役立ちますが、間違ったマイクロプレートはデータの欠落や不正確さを招き、プロジェクトのタイムラインや最終的なコストの上昇につながります。
Learn more | View products
microplate readers

マイクロプレートリーダー

Revvityのプレートリーダー製品群は、今日のラボの多様なアッセイ要件に対応する最新の検出技術を備えています。
Learn more
Immunoassays-New-512x288

Immunoassays

Since their introduction in the 1950’s, immunoassays have been an integral part of research and drug discovery.

Learn more
全てを表示 View less

Featured resources

Publication Review

Next-generation antimalarials - new hope on the horizon

Learn more
Brochure

Solutions for infectious disease research and discovery

Learn more
Publication Review

hESC-derived cardiomyocyte screening platform identifies novel inhibitors of SARS-Cov-2 viral entry

Learn more
White Paper

Learning from our ancestors: can we be better prepared for the next pandemic?

Learn more
White Paper

Lentiviral high-throughput assay shows promise for identifying novel HIV-1 inhibitors

Learn more
View all resources View all resources

Featured blogs

Blog global TB report thumbnail
The Global TB Report 2023 shows progress but also highlights what is needed to eradicate TB by 2030.

The annual Global Tuberculosis (TB) Report from the World Health Organization (WHO) provides an up-to-date assessment of the global TB epidemic, the progress made, and the new and existing challenges to that progress.

Blog fight against TB thumbnail
A journey through time: the fight against tuberculosis.

World TB Day falls on the 24th of March every year. On this day in 1882, Dr. Robert Koch first announced that he had isolated the bacillus Mycobacterium tuberculosis, which was responsible for causing tuberculosis (TB).

Killing Cancer With Bacteria
Killing cancer with bacteria.

When most of us encounter bacteria, we reach for a sanitizer. Researchers at the Cork Cancer Research Centre in Cork, Ireland, have a much different reaction.

The Important Role In Vivo Bioluminescence Imaging Plays in COVID-19 Research
The important role in vivo bioluminescence imaging plays in COVID-19 research.

In February 2020, just before the World Health Organization (WHO) declared COVID-19 a global pandemic, WHO Director-General Dr Tedros Adhanom Ghebreyesus stated that bringing the outbreak under control would necessitate harnessing the power of science.

ご質問がございましたら、
お気軽にお問い合わせください。

お問合せ
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.